Various biologics that focus on the IL-17 pathway are currently being studied.
Mariah Zebrowski Leach, JD, MS
New data highlight the role of the C5a-C5aR axis in the onset of inflammation.
Recently published EULAR/ACR classification criteria generally perform better than previous criteria.
No differences were observed in patellofemoral joint morphology between asymptomatic patients and those with pain.
Mepolizumab gets the nod for the rare disease formerly known as Churg-Strauss syndrome.
A commonly held belief has been debunked.
Limbrel capsules linked to potentially life-threatening health problems.
The aim of this study: to determine which patients need biologic therapy after starting methotrexate.
What underlies the disparity in life expectancy between men and women with SLE?
The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.